Patents by Inventor Mark C. Brister

Mark C. Brister has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Analyte sensor
    Patent number: 10918313
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: July 8, 2020
    Date of Patent: February 16, 2021
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Steve Masterson, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Peter C. Simpson, Vance Swanson, Matthew D. Wightlin
  • Analyte sensor
    Patent number: 10918314
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: July 8, 2020
    Date of Patent: February 16, 2021
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Steve Masterson, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Peter C. Simpson, Vance Swanson, Matthew D. Wightlin
  • ANALYTE SENSOR
    Publication number: 20210022653
    Abstract: Biointerface membranes are provided which can be utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, methods for monitoring glucose levels in a biological fluid sample using an implantable analyte detection device incorporating such membranes are provided.
    Type: Application
    Filed: September 28, 2020
    Publication date: January 28, 2021
    Inventors: James H. Brauker, Robert J. Boock, Monica A. Rixman, Peter C. Simpson, Mark C. Brister, Mark C. Shults
  • TRANSCUTANEOUS ANALYTE SENSOR
    Publication number: 20200405203
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: September 14, 2020
    Publication date: December 31, 2020
    Inventors: Mark C. Brister, Paul V. Neale, James R. Petisce, James Patrick Thrower, Sean Saint, John Nolting
  • Intragastric volume-occupying device and method for fabricating same
    Patent number: 10874537
    Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: December 29, 2020
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D. L. VandenBerg
  • ANALYTE SENSORS HAVING A SIGNAL-TO-NOISE RATIO SUBSTANTIALLY UNAFFECTED BY NON-CONSTANT NOISE
    Publication number: 20200397291
    Abstract: Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.
    Type: Application
    Filed: September 1, 2020
    Publication date: December 24, 2020
    Inventors: Peter C. Simpson, Robert J. Boock, Mark C. Brister, Monica A. Rixman, Kum Ming Woo, Lisa Nguyen, Seth R. Brunner, Arthur Chee, Melissa A. Nicholas, Matthew D. Wightlin, Jack Pryor, Dubravka Markovic
  • ANALYTE SENSOR
    Publication number: 20200367794
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: July 8, 2020
    Publication date: November 26, 2020
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin
  • ANALYTE SENSOR
    Publication number: 20200359949
    Abstract: The present invention relates generally to biointerface membranes utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, the invention relates to novel biointerface membranes, to devices and implantable devices including these membranes, methods for forming the biointerface membranes on or around the implantable devices, and to methods for monitoring glucose levels in a biological fluid sample using an implantable analyte detection device.
    Type: Application
    Filed: July 14, 2020
    Publication date: November 19, 2020
    Inventors: James H. Brauker, Peter C. Simpson, Robert J. Boock, Monica Rixman Swinney, Mark C. Brister
  • TRANSCUTANEOUS MEDICAL DEVICE WITH VARIABLE STIFFNESS
    Publication number: 20200352483
    Abstract: The present invention relates generally to variable stiffness transcutaneous medical devices including a distal portion designed to be more flexible than a proximal portion. The variable stiffness can be provided by a variable pitch in one or more wires of the device, a variable cross-section in one or more wires of the device, and/or a variable hardening and/or softening in one or more wires of the device.
    Type: Application
    Filed: July 29, 2020
    Publication date: November 12, 2020
    Inventors: Mark C. Brister, James H. Brauker
  • Analyte sensor
    Patent number: 10827956
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: November 10, 2020
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Peter C. Simpson, Matthew D. Wightlin, Steve Masterson, James R. Petisce, John Nolting, Jack Pryor, Sean Saint, Vance Swanson, James H. Brauker, Apurv Ullas Kamath, Paul V. Goode, Jr., Aarthi Mahalingam
  • ANALYTE SENSOR
    Publication number: 20200337616
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: July 8, 2020
    Publication date: October 29, 2020
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, JR., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin
  • ANALYTE SENSOR
    Publication number: 20200337617
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: July 8, 2020
    Publication date: October 29, 2020
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, JR., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin
  • ANALYTE SENSOR
    Publication number: 20200337618
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: July 8, 2020
    Publication date: October 29, 2020
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, JR., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin
  • Analyte sensor
    Patent number: 10813577
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: October 27, 2020
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, James R. Petisce, Kum Ming Woo, Victor Ha, Melissa A. Nicholas, Peter C. Simpson, Matthew D. Wightlin, Steve Masterson, John Nolting, Jack Pryor, Sean Saint, Vance Swanson
  • Analyte sensor
    Patent number: 10813576
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: October 27, 2020
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Steve Masterson, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Peter C. Simpson, Vance Swanson, Matthew D. Wightlin
  • Analyte sensor
    Patent number: 10799158
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: October 13, 2020
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Steve Masterson, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Peter C. Simpson, Vance Swanson, Matthew D. Wightlin
  • Analyte sensor
    Patent number: 10799159
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: October 13, 2020
    Assignee: DexCom, Inc.
    Inventors: Mark C. Brister, Steve Masterson, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Peter C. Simpson, Vance Swanson, Matthew D. Wightlin
  • Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
    Patent number: 10791928
    Abstract: Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: October 6, 2020
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Robert J. Boock, Mark C. Brister, Monica A. Rixman, Kum Ming Woo, Lisa Nguyen, Seth R. Brunner, Arthur Chee, Melissa A. Nicholas, Matthew D. Wightlin, Jack Pryor, Dubravka Markovic
  • Pressure control system for intragastric device
    Patent number: 10772752
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: September 15, 2020
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Neil R. Drake, Daniel J. Proctor, Madeline Campbell
  • Intragastric device
    Patent number: 10773061
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: September 15, 2020
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Andrew P. Rasdal, Neil R. Drake, Amy D. L. VandenBerg